These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17459270)

  • 1. Managing the local complications of locally advanced prostate cancer.
    Anast JW; Andriole GL; Grubb RL
    Curr Urol Rep; 2007 May; 8(3):211-6. PubMed ID: 17459270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer.
    Kamat AM; Huang SF; Bermejo CE; Rosser CJ; Pettaway CA; Pisters PW; Guitreau D; Pisters LL
    J Urol; 2003 Nov; 170(5):1868-71. PubMed ID: 14532795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of specific complications of locally advanced prostate cancer].
    von Rundstedt FC; Brandt AS; Lazica D; Mathers MJ; Roth S
    Urologe A; 2008 Nov; 47(11):1453-9. PubMed ID: 18825358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transitional cell carcinoma of the prostate in cystoprostatectomy specimens].
    Liedberg F; Chebil G; Davidsson T; Malmström PU; Sherif A; Månsson W
    Aktuelle Urol; 2003 Sep; 34(5):333-6. PubMed ID: 14566661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative MRI-guided transurethral ultrasound ablation for symptomatic locally advanced prostate cancer.
    Anttinen M; Mäkelä P; Nurminen P; Yli-Pietilä E; Suomi V; Sainio T; Saunavaara J; Taimen P; Blanco Sequeiros R; Boström PJ
    Scand J Urol; 2020 Dec; 54(6):481-486. PubMed ID: 32897169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer.
    Leibovici D; Kamat AM; Pettaway CA; Pagliaro L; Rosser CJ; Logothetis C; Pisters LL
    J Urol; 2005 Dec; 174(6):2186-90. PubMed ID: 16280761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
    Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
    ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer.
    Leibovici D; Kamat AM; Do KA; Pettaway CA; Ng CS; Evans RB; Rodriguez-Bigas M; Skibber J; Wang X; Pisters LL
    Prostate; 2005 Jan; 62(1):101-4. PubMed ID: 15389800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary outcomes of palliative transurethral resection of the prostate in patients with locally advanced prostate cancer.
    Pelletier J; Cyr SJ; Julien AS; Fradet Y; Lacombe L; Toren P
    Urol Oncol; 2018 Aug; 36(8):363.e7-363.e11. PubMed ID: 29880461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does urethral-sparing prostatectomy risk residual prostate cancer?
    Tongco WP; Wehner MS; Basler JW
    Urology; 2001 Mar; 57(3):495-8. PubMed ID: 11248627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the correct staging and treatment strategy for locally advanced prostate cancer extending to the bladder?
    Yüksel ÖH; Verit A; Ürkmez A
    Arch Ital Urol Androl; 2015 Jul; 87(2):130-5. PubMed ID: 26150029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [When should the primary tumor of metastatic bladder or prostate cancer be treated using a nonsurgical regimen?].
    Bottke D; Bolenz C; Ott S; Cebulla A; Wiegel T
    Urologe A; 2017 May; 56(5):579-584. PubMed ID: 28349190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of transurethral resection in cancer of the prostate].
    Rodríguez JV; Chechile G
    Arch Esp Urol; 1989; 42 Suppl 2():165-77. PubMed ID: 2639620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical management of a locally advanced symptomatic recurrence of penile sarcoma secondary to prostate brachytherapy.
    Hakky TS; Espiritu P; Rodriguez AR; Gould N; Spiess PE
    Int Braz J Urol; 2013; 39(2):293-4. PubMed ID: 23683678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.
    Kouba E; Wallen EM; Pruthi RS
    J Urol; 2008 Aug; 180(2):444-50. PubMed ID: 18550089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of obstructive uropathy in advanced prostate cancer.
    Oefelein MG
    Urology; 2004 Jun; 63(6):1117-21. PubMed ID: 15183963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metal mesh stents for ureteral obstruction caused by hormone-resistant carcinoma of prostate.
    Ahmed M; Bishop MC; Bates CP; Manhire AR
    J Endourol; 1999 Apr; 13(3):221-4. PubMed ID: 10360504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastatic esophageal adenocarcinoma to the prostate presenting with bilateral ureteral obstruction.
    Marlin ES; Hyams ES; Dulabon L; Shah O
    Can J Urol; 2010 Feb; 17(1):5035-7. PubMed ID: 20156389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of cystoprostatectomy in locally advanced prostate carcinoma].
    Zantl N; Gschwend JE
    Urologe A; 2008 Nov; 47(11):1447-52. PubMed ID: 18810382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.